Going
Conditions
Interventions
First group received BSCPB with ropivacaine 0.2 %plus 1ml normal saline intravenously (Group C)
second group received BSCPB with ropivacaine 0.2%, 8mg dexamethazone in the block plus 1ml normal saline
Sponsors
Anesthesia department Mansoura university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA (physical status) I or II. undergoing thyroid surgeries
Exclusion criteria
Exclusion criteria: obstructive pulmonary disease, diabetes, neuropathy, history of allergy to any of the used drugs, epilepsy, neuromuscular disease, or hematological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the primary concern is to compare effect of dexamethasone in association with superficial cervical plexus block in patients undergoing thyroid surgery by two routes; intravenous and perineural. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary goals are effect upon pain scores, PONV, and hospital stay. | — |
Countries
Africa
Contacts
Public ContactDr Khaled Elbahrawy
Mansoura university hospital Anesthesia
Outcome results
None listed